Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients
The pandemic of COVID-19 caused by SARS-CoV-2 infection continues to spread around the world. Vaccines that elicit protective immunity have reduced infection and mortality, however new viral variants are arising that may evade vaccine-induced immunity or cause disease in individuals who are unable t...
Main Authors: | Xufang Deng, Monika Evdokimova, Amornrat O’Brien, Cynthia L. Rowe, Nina M. Clark, Amanda Harrington, Gail E. Reid, Susan L. Uprichard, Susan C. Baker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/9/1743 |
Similar Items
-
Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients
by: Marco Masetti, et al.
Published: (2023-03-01) -
Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine
by: Floriane Gallais, et al.
Published: (2022-02-01) -
Outcome of SARS-CoV-2 variant breakthrough infection in fully immunized solid organ transplant recipients
by: Reem S. Almaghrabi, et al.
Published: (2022-01-01) -
Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections
by: Jing Zou, et al.
Published: (2022-08-01) -
COVID–19 breakthrough infection after four doses of the vaccines: A case report
by: Hongrang Zhou, et al.
Published: (2023-01-01)